Pathogenic  	Pathogenic  	 NNP	B-NP
and  	and  	 CC	O
clinical  	clinical  	 JJ	B-NP
presentation  	presentation  	 NN	I-NP
of  	of  	 IN	I-NP
bullous  	bullous  	 JJ	I-NP
rash  	rash  	 NN	I-NP
in  	in  	 IN	O
hand 	hand 	 NN	O
,  	,  	 ,	O
foot  	foot  	 NN	O
and  	and  	 CC	O
mouth  	mouth  	 NN	O
disease  	disease  	 NN	O
To  	To  	 TO	O
investigate  	investigate  	 VB	O
the  	the  	 DT	O
pathogenic  	pathogenic  	 NN	B-NP
and  	and  	 CC	O
clinical  	clinical  	 JJ	B-NP
presentation  	presentation  	 NN	I-NP
and  	and  	 CC	O
laboratory  	laboratory  	 NN	B-NP
tests  	tests  	 NNS	I-NP
of  	of  	 IN	I-NP
bullous  	bullous  	 JJ	I-NP
rash  	rash  	 NN	I-NP
in  	in  	 IN	O
hand 	hand 	 NN	B-NP
,  	,  	 ,	I-NP
foot  	foot  	 NN	I-NP
and  	and  	 CC	I-NP
mouth  	mouth  	 NN	I-NP
disease  	disease  	 NN	I-NP
( 	( 	 -LRB-	O
HFMD 	HFMD 	 NNP	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
Xi 	Xi 	 NNP	O
' 	' 	 POS	O
an  	an  	 NN	O
from  	from  	 IN	O
January  	January  	 NNP	O
2013  	2013  	 CD	O
to  	to  	 TO	O
December  	December  	 NNP	O
2014  	2014  	 CD	O
by  	by  	 IN	O
retrospective  	retrospective  	 JJ	B-NP
analysis 	analysis 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
total  	total  	 NN	O
of  	of  	 IN	O
224  	224  	 CD	O
specimens  	specimens  	 NNS	O
were  	were  	 VBD	O
collected  	collected  	 VBN	O
from  	from  	 IN	O
clinically  	clinically  	 NN	O
diagnosed  	diagnosed  	 VBD	B-NP
HFMD  	HFMD  	 NNP	I-NP
cases  	cases  	 NNS	I-NP
who  	who  	 WP	O
were  	were  	 VBD	O
characterized  	characterized  	 VBN	O
by  	by  	 IN	O
widespread  	widespread  	 JJ	O
mucocutaneous  	mucocutaneous  	 JJ	B-NP
bullous  	bullous  	 JJ	I-NP
reactions  	reactions  	 NNS	I-NP
in  	in  	 IN	O
Xi 	Xi 	 NNP	O
' 	' 	 ''	O
an  	an  	 DT	O
Children 	Children 	 NNP	O
's  	's  	 POS	O
Hospital  	Hospital  	 NN	O
from  	from  	 IN	O
January  	January  	 NNP	O
2013  	2013  	 CD	O
to  	to  	 TO	O
December  	December  	 NNP	O
2014 	2014 	 CD	O
,  	,  	 ,	O
the  	the  	 DT	O
identification  	identification  	 NN	B-NP
and  	and  	 CC	O
subtyping  	subtyping  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
isolates  	isolates  	 NN	O
were  	were  	 VBD	O
conducted  	conducted  	 VBN	O
with  	with  	 IN	O
real-time  	real-time  	 JJ	B-NP
fluorescent  	fluorescent  	 JJ	O
quantitative  	quantitative  	 JJ	B-NP
RT-PCR 	RT-PCR 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
retrospective  	retrospective  	 JJ	B-NP
analysis  	analysis  	 NN	I-NP
was  	was  	 VBD	O
performed  	performed  	 VBN	O
to  	to  	 TO	O
analyze  	analyze  	 VB	O
the  	the  	 DT	O
clinical  	clinical  	 JJ	B-NP
presentation 	presentation 	 NN	I-NP
,  	,  	 ,	O
laboratory  	laboratory  	 NN	B-NP
tests  	tests  	 NNS	I-NP
and  	and  	 CC	O
late  	late  	 JJ	O
follow-up  	follow-up  	 JJ	B-NP
problems  	problems  	 NNS	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
HFMD 	HFMD 	 NNP	I-NP
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
clinically  	clinically  	 NN	O
diagnosed  	diagnosed  	 VBD	B-NP
HFMD  	HFMD  	 NNP	I-NP
cases  	cases  	 NNS	I-NP
who  	who  	 WP	O
were  	were  	 VBD	O
characterized  	characterized  	 VBN	O
by  	by  	 IN	O
widespread  	widespread  	 JJ	O
mucocutaneous  	mucocutaneous  	 JJ	B-NP
bullous  	bullous  	 JJ	I-NP
reactions 	reactions 	 NNS	I-NP
,  	,  	 ,	O
207  	207  	 CD	O
were  	were  	 VBD	O
caused  	caused  	 VBN	O
by  	by  	 IN	O
coxsackievirus  	coxsackievirus  	 CD	B-NP
A6  	A6  	 CD	I-NP
( 	( 	 -LRB-	O
CA6 	CA6 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
accounting  	accounting  	 NN	O
for  	for  	 IN	O
92.  	92.  	 CD	O
4 	4 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
all  	all  	 DT	O
cases  	cases  	 NNS	O
with  	with  	 IN	O
bullous 	bullous 	 NN	B-NP
,  	,  	 ,	O
4  	4  	 CD	O
were  	were  	 VBD	O
caused  	caused  	 VBN	O
by  	by  	 IN	O
enterovirus  	enterovirus  	 CD	B-NP
71  	71  	 CD	O
( 	( 	 -LRB-	O
EV71 	EV71 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
accounting  	accounting  	 NN	O
for  	for  	 IN	O
1.8 	1.8 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
10  	10  	 CD	O
were  	were  	 VBD	O
caused  	caused  	 VBN	O
by  	by  	 IN	O
coxsackievirus  	coxsackievirus  	 CD	B-NP
A16  	A16  	 CD	I-NP
( 	( 	 -LRB-	O
CA16 	CA16 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
accounting  	accounting  	 NN	O
for  	for  	 IN	O
4.  	4.  	 CD	O
5 	5 	 CD	O
% 	% 	 NN	O
;  	;  	 :	O
4  	4  	 CD	O
cases  	cases  	 NNS	O
were  	were  	 VBD	O
negative  	negative  	 JJ	O
for  	for  	 IN	O
these  	these  	 DT	O
viruses 	viruses 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
cases  	cases  	 NNS	O
positive  	positive  	 JJ	O
for  	for  	 IN	O
intestinal  	intestinal  	 JJ	B-NP
virus-nucleic  	virus-nucleic  	 JJ	I-NP
acid 	acid 	 NN	I-NP
,  	,  	 ,	O
130  	130  	 CD	O
were  	were  	 VBD	O
male 	male 	 JJ	O
,  	,  	 ,	O
90  	90  	 CD	O
were  	were  	 VBD	O
female 	female 	 JJ	O
;  	;  	 :	O
male  	male  	 JJ	O
to  	to  	 TO	O
female  	female  	 JJ	O
ratio  	ratio  	 NN	O
was  	was  	 VBD	O
1.  	1.  	 CD	O
44 	44 	 CD	O
:  	:  	 :	O
1 	1 	 CD	O
,  	,  	 ,	O
203  	203  	 CD	O
were  	were  	 VBD	O
< 	< 	 SYM	O
5  	5  	 CD	O
years  	years  	 NNS	O
old 	old 	 JJ	O
,  	,  	 ,	O
accounting  	accounting  	 NN	O
for  	for  	 IN	O
92.  	92.  	 CD	O
3 	3 	 CD	O
% 	% 	 NN	O
.  	.  	 .	O
Leukocytosis  	Leukocytosis  	 NNP	B-NP
was  	was  	 VBD	O
found  	found  	 VBN	O
in  	in  	 IN	O
75  	75  	 CD	O
cases  	cases  	 NNS	O
( 	( 	 -LRB-	O
34.  	34.  	 CD	O
1 	1 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
;  	;  	 :	O
high-sensitivity  	high-sensitivity  	 JJ	B-NP
C-reactive  	C-reactive  	 JJ	I-NP
protein  	protein  	 NN	I-NP
( 	( 	 -LRB-	O
hsCRP 	hsCRP 	 NNP	B-NP
)  	)  	 -RRB-	O
increased  	increased  	 VBD	O
in  	in  	 IN	O
200  	200  	 CD	O
cases  	cases  	 NNS	O
( 	( 	 -LRB-	O
90.  	90.  	 CD	O
9 	9 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
;  	;  	 :	O
elevated  	elevated  	 FW	B-NP
myocardial  	myocardial  	 FW	I-NP
enzyme  	enzyme  	 FW	I-NP
CK-MB  	CK-MB  	 NNP	I-NP
was  	was  	 VBD	O
found  	found  	 VBN	O
in  	in  	 IN	O
35  	35  	 CD	O
cases  	cases  	 NNS	O
( 	( 	 -LRB-	O
15.  	15.  	 CD	O
9 	9 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
alanine  	alanine  	 NNS	B-NP
aminotransferase  	aminotransferase  	 VBP	O
increased  	increased  	 VBN	O
in  	in  	 IN	O
15  	15  	 CD	O
cases  	cases  	 NNS	O
( 	( 	 -LRB-	O
6.  	6.  	 CD	O
8 	8 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
;  	;  	 :	O
187  	187  	 CD	O
cases  	cases  	 NNS	O
had  	had  	 VBD	O
fever  	fever  	 NN	O
( 	( 	 -LRB-	O
85.  	85.  	 CD	O
0 	0 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
None  	None  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
cases  	cases  	 NNS	O
had  	had  	 VBD	O
serious  	serious  	 JJ	B-NP
complications  	complications  	 NNS	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
encephalitis  	encephalitis  	 NN	O
or  	or  	 CC	O
myocarditis 	myocarditis 	 NN	B-NP
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
course  	course  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
critical  	critical  	 JJ	B-NP
phase  	phase  	 NN	I-NP
bullous  	bullous  	 NN	I-NP
rash  	rash  	 NN	I-NP
or  	or  	 CC	O
large  	large  	 JJ	O
vesicle-like  	vesicle-like  	 JJ	B-NP
changes 	changes 	 NNS	I-NP
,  	,  	 ,	O
obvious  	obvious  	 JJ	O
itching 	itching 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
facial  	facial  	 JJ	B-NP
rash  	rash  	 NN	I-NP
appeared 	appeared 	 VBD	O
.  	.  	 .	O
After  	After  	 IN	O
the  	the  	 DT	O
fluid  	fluid  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
bullae  	bullae  	 NN	B-NP
was  	was  	 VBD	O
absorbed  	absorbed  	 VBN	O
or  	or  	 CC	O
the  	the  	 DT	O
bullae  	bullae  	 JJ	B-NP
ruptured  	ruptured  	 NN	I-NP
or  	or  	 CC	O
became  	became  	 VBD	O
ulcerated 	ulcerated 	 CD	O
,  	,  	 ,	O
scar  	scar  	 JJ	O
formation  	formation  	 NN	O
and  	and  	 CC	O
large  	large  	 JJ	O
areas  	areas  	 NNS	O
of  	of  	 IN	O
exfoliation  	exfoliation  	 NN	B-NP
occurred 	occurred 	 VBD	O
,  	,  	 ,	O
with  	with  	 IN	O
no  	no  	 DT	O
effusion  	effusion  	 NN	B-NP
on  	on  	 IN	O
the  	the  	 DT	O
newly  	newly  	 RB	O
formed  	formed  	 VBN	O
epithelium  	epithelium  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
base 	base 	 NN	O
,  	,  	 ,	O
without  	without  	 IN	O
significant  	significant  	 JJ	O
pigmentation  	pigmentation  	 NN	O
on  	on  	 IN	O
later  	later  	 RB	O
follow-up 	follow-up 	 JJ	O
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
late  	late  	 RB	O
follow  	follow  	 VB	O
up  	up  	 RP	O
process 	process 	 NN	O
,  	,  	 ,	O
52  	52  	 CD	O
cases  	cases  	 NNS	O
in  	in  	 IN	O
CA6-positive  	CA6-positive  	 CD	B-NP
patients  	patients  	 NNS	I-NP
( 	( 	 -LRB-	O
25.  	25.  	 CD	O
1 	1 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
developed  	developed  	 VBD	O
onychomadesis  	onychomadesis  	 VBN	O
within  	within  	 IN	O
2-4  	2-4  	 CD	O
weeks  	weeks  	 NNS	O
after  	after  	 IN	O
onset 	onset 	 NN	O
,  	,  	 ,	O
1  	1  	 CD	O
to  	to  	 TO	O
8  	8  	 CD	O
nails 	nails 	 NN	O
,  	,  	 ,	O
an  	an  	 DT	O
average  	average  	 NN	O
of  	of  	 IN	O
4.  	4.  	 CD	O
3  	3  	 CD	O
fell  	fell  	 VBD	O
off 	off 	 RP	O
,  	,  	 ,	O
new  	new  	 JJ	O
nails  	nails  	 NN	O
grew 	grew 	 VBD	O
,  	,  	 ,	O
the  	the  	 DT	O
nail  	nail  	 JJ	O
bed  	bed  	 NN	O
showed  	showed  	 VBD	O
no  	no  	 DT	O
structural  	structural  	 JJ	B-NP
abnormalities  	abnormalities  	 NN	I-NP
and  	and  	 CC	O
hyperplasia  	hyperplasia  	 NN	B-NP
after  	after  	 IN	O
falling  	falling  	 VBG	O
off 	off 	 RP	O
,  	,  	 ,	O
the  	the  	 DT	O
surface  	surface  	 NN	O
was  	was  	 VBD	O
smooth 	smooth 	 JJ	O
,  	,  	 ,	O
had  	had  	 VBD	O
no  	no  	 DT	O
hypertrophy 	hypertrophy 	 NN	B-NP
,  	,  	 ,	O
left  	left  	 VBD	O
no  	no  	 DT	O
sequelae 	sequelae 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
pathogen  	pathogen  	 NN	O
in  	in  	 IN	O
HFMD  	HFMD  	 NNP	B-NP
characterized  	characterized  	 VBD	O
by  	by  	 IN	O
widespread  	widespread  	 JJ	O
bullous  	bullous  	 JJ	B-NP
reactions  	reactions  	 NNS	I-NP
was  	was  	 VBD	O
mainly  	mainly  	 RB	O
the  	the  	 DT	O
CA6 	CA6 	 NNP	B-NP
,  	,  	 ,	O
this  	this  	 DT	O
kind  	kind  	 NN	O
of  	of  	 IN	O
HFMD  	HFMD  	 NNP	B-NP
was  	was  	 VBD	O
mainly  	mainly  	 RB	O
mild  	mild  	 JJ	O
type 	type 	 NN	O
,  	,  	 ,	O
with  	with  	 IN	O
significant  	significant  	 JJ	O
itching 	itching 	 NN	O
,  	,  	 ,	O
later  	later  	 RB	O
the  	the  	 DT	O
bullae  	bullae  	 NN	B-NP
may  	may  	 MD	O
have  	have  	 VB	O
scar  	scar  	 JJ	O
formation  	formation  	 NN	O
and  	and  	 CC	O
skin  	skin  	 NN	B-NP
exfoliation 	exfoliation 	 NN	I-NP
,  	,  	 ,	O
in  	in  	 IN	O
some  	some  	 DT	O
cases  	cases  	 NNS	O
onychomadesis  	onychomadesis  	 NN	B-NP
may  	may  	 MD	O
occur 	occur 	 VB	O
.  	.  	 .	O
